A Comparison of Respiratory Sample Collection by a Parent or by a Healthcare Worker
NCT ID: NCT00966069
Last Updated: 2016-03-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
64 participants
INTERVENTIONAL
2009-08-31
2010-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Quantifying Viral Load in Respiratory Particles That Are Generated by Children and Adults With COVID-19 Infection
NCT05195229
Validation of the Respirio Flu Test for the Rapid Identification of Influenza A/B
NCT01431768
Capturing Infectious COVID-19 Asymptomatic Cases in Singapore
NCT04812327
Perspectives on Antibiotics and Tracking Symptoms in Children
NCT07093749
To Evaluate Mucosal and Systematic Immune Response to Acute Respiratory Tract Infections of South African Children
NCT06902194
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In order to prepare for a larger, community based study, we would like to test these findings in our environment.
Community-based respiratory infection research has traditionally been conducted by home visit from a health care worker during illness to collect a sample, such as a nasopharyngeal aspirate. This method has the potential to result in non-reporting of illness or failure to collect a specimen due to the invasive nature of specimen collection or the difficulty arranging a home visit time that is convenient for parents and staff. This may bias findings and interfere with generalisability.
Home collection of a simple respiratory sample has recently been demonstrated as an easy and acceptable method of conducting community-based respiratory research. Members of our group were involved in a large, community-based study in Melbourne involving 234 children and their families over a 12-month period. On this study parents successfully kept daily respiratory symptom diaries and collected a combined nose-throat swab when the child had an illness that met the definition for an acute respiratory illness (ARI) of interest. These study methods were acceptable with 87% parents reporting, at the end of the study, they would have been willing to continue with the study for at least another year.
Since that study, parent collection of simple respiratory specimens has been further validated in the hospital setting and used in the home setting.
We have previously shown that a swab combined with viral transport medium-soaked sponge in a secure transport tube is an efficient and safe way of transporting respiratory swabs. The method complies with guidelines for the transport of clinical specimens. As part of this study, we will use this system to allow for the transport of respiratory specimens to the Queensland Paediatric Infectious Diseases (Qpid) Laboratory through the normal surface mail, thereby allowing study families to manage specimen collection and return without the intervention of a study staff member.
Flocked swabs in combination with specific viral transport media have recently been added to specimen collection options, allowing for simple and sensitive specimen collection whilst avoiding more invasive nasopharyngeal aspirates or washes.
With this study, we plan to compare parent and health care worker collection using flocked swabs, and for some specimens they will be returned to the laboratory through normal surface mail.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Healthcare worker visit
Healthcare worker performs home visit when study child has acute respiratory illness to collect a respiratory swab (nasopharyngeal swab).
At the healthcare worker home visit, the HCW will collect the nasopharyngeal swab, and a parent will collect an anterior nasal swab. The HCW swab is to be returned immediately to the laboratory, and the parent collected swab was placed in a post box for return to the laboratory by surface mail.
Healthcare worker home visit
Healthcare worker performs home visit for collection of respiratory specimen (anterior nose) when study child has an acute respiratory illness.
Parent collection
Home collection of respiratory swab (anterior nose) and mailed return when study subject has an acute respiratory illness.
Parent collection
Parent collection of anterior nose specimen when child has an acute respiratory illness, and mailed return of the specimen to the laboratory.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Parent collection
Parent collection of anterior nose specimen when child has an acute respiratory illness, and mailed return of the specimen to the laboratory.
Healthcare worker home visit
Healthcare worker performs home visit for collection of respiratory specimen (anterior nose) when study child has an acute respiratory illness.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* born between 36 and 42 weeks gestational age
* written informed consent from parent/guardian (available for telephone contact)
* parent willing to collect an anterior nasal specimen from the study child when meets criteria for ARI of interest
Exclusion Criteria
* children with chronic metabolic disorders (such as but not limited to diabetes mellitis, renal dysfunction, haemoglobinopathies)
* children with immune system disorders (such as HIV/AIDS or receiving immune system suppressing medications)
* children with other chronic illnesses whose enrolment is deemed by the investigators to make it inappropriate to enrol them onto the study
* parent or guardian with sufficient English language skills to complete study diaries and perform study tasks as required
2 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The University of Queensland
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr Stephen Lambert
Senior Research Fellow
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Keith Grimwood, MD
Role: PRINCIPAL_INVESTIGATOR
The University of Queensland
Theo P Sloots, PhD
Role: PRINCIPAL_INVESTIGATOR
Queensland Paediatric Infectious Diseases Laboratory
Michael D Nissen, FRACP
Role: PRINCIPAL_INVESTIGATOR
Queensland Paediatric Infectious Disease Laboratory
Stephen B Lambert, MBBS
Role: PRINCIPAL_INVESTIGATOR
Queensland Paediatric Infectious Diseases Laboratory
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Queensland Children's Medical Research Institute
Brisbane, Queensland, Australia
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Zoch-Lesniak B, Ware RS, Grimwood K, Lambert SB. The Respiratory Specimen Collection Trial (ReSpeCT): A Randomized Controlled Trial to Compare Quality and Timeliness of Respiratory Sample Collection in the Home by Parents and Healthcare Workers From Children Aged <2 Years. J Pediatric Infect Dis Soc. 2020 Apr 30;9(2):134-141. doi: 10.1093/jpids/piy136.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HREC/09/QRCH/42
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.